News overview GKC

Dapagliflozin reduces risk for hospitalization in patients with CKD with or without diabetes

Dapagliflozin, a sodium-glucose cotransporter-2 (SGLT2) inhibitor, reduced the risk for hospitalization for any cause in patients wit…
Podcast about kidney transplantation, nutrition and health

Gerjan Navis is an internist-nephrologist at the UMCG. She is professor of Experimental Nephrology (2000) and holds an endowed chair Nutrition in Medicine (2015).
Transplant kidney survival rate improves with new method of transportation

New research by the Consortium for Organ Preservation in Europe (COPE) has found that a new method to transport donor kidneys, which …

— 4 Items per Page

Resultats 9 - 11 of 11